학술논문
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
Document Type
Article
Author
Dytfeld, Dominik; Wróbel, Tomasz; Jamroziak, Krzysztof; Kubicki, Tadeusz; Robak, Paweł; Walter-Croneck, Adam; Czyż, Jarosław; Tyczyńska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Nowicki, Adam; Szczepaniak, Tomasz; Łojko-Dankowska, Anna; Matuszak, Magdalena; Gil, Lidia; Puła, Bartosz; Rybka, Justyna; Majcherek, Maciej; Usnarska-Zubkiewicz, Lidia; Szukalski, Łukasz; Końska, Agnieszka; Zaucha, Jan Maciej; Walewski, Jan; Mikulski, Damian; Czabak, Olga; Robak, Tadeusz; Lahoud, Oscar B; Zonder, Jeffrey A; Griffith, Kent; Stefka, Andrew; Major, Ajay; Derman, Benjamin A; Jakubowiak, Andrzej J
Source
In The Lancet Oncology February 2023 24(2):139-150
Subject
Language
ISSN
1470-2045